Emergency: 9010550550
24/7 Service

Brain Tumor Surgery at Ajuda Hospitals

Microscopy, neuronavigation and IONM protocols under NABH safety for maximal safe resection

Book Brain Tumor Surgery Consultation
92–96%
Extent of Resection (eligible benign tumors)
Microscope and image-guidance improve margin achievement
48–72 hrs
Typical Ward Stay
For uncomplicated cases with ERAS-style protocols
3–5%
Major Complication Rate
Aligned to international benchmarks in suitable cases

When to Consult

  • Persistent or progressive headaches with early morning vomiting
  • New seizures or focal weakness/tingling
  • Vision, speech or balance changes
  • Hormonal symptoms suggestive of pituitary tumors
  • Incidental brain lesion reported on CT/MRI
  • Prior tumor surgery with new symptoms or growth on follow-up scans

Understanding Brain Tumors in the Indian Context

Brain tumors range from benign meningiomas to high-grade gliomas. In India, delays can occur due to attributing headaches or seizures to stress or screen time. Our Hyderabad-first approach prioritises early MRI access, multidisciplinary planning and clear counselling in Telugu, Hindi, Urdu and English.

Family responsibilities, travel from districts like Warangal or Karimnagar, and insurance paperwork are factored into our scheduling so treatment is not delayed.

When to Consult Our Brain Tumor Surgery Specialists

Seek urgent care if you notice:
  • ✓ New seizures or sudden worsening headaches
  • ✓ Weakness/numbness on one side of the body
  • ✓ Sudden vision, speech or balance changes
  • ✓ Persistent vomiting with early morning headaches
Book a routine consult if you have:
  • ✓ MRI/CT showing a brain lesion
  • ✓ Hormonal symptoms suggesting pituitary tumor
  • ✓ Prior tumor surgery with new symptoms or growth

Our Diagnostic Approach

Focused Imaging

MRI with contrast (plus diffusion/perfusion for gliomas). CT for acute bleed or raised pressure. Angio studies for vascular proximity.

Multidisciplinary Tumor Board

Neurosurgery, radiology, anaesthesia and oncology decide resection vs biopsy vs surveillance, referencing ICMR and international guidance.

Pre-Op Optimisation

Seizure control, steroids for edema, DVT prophylaxis risk assessment, consent with realistic outcomes.

Navigation & IONM Setup

Registration to neuronavigation, mapping plan and cranial nerve/tract monitoring checklist.

Treatment Pathways

  • Microscope Resection → standard for accessible benign tumors.
  • Navigation-Guided Resection → for eloquent locations or deep lesions.
  • Endoscopic Endonasal → pituitary and select skull base; co-managed with ENT.
  • Stereotactic Biopsy → when tissue diagnosis is needed prior to therapy.
  • Adjuvant Therapy → neuro-oncology plan after histopathology (RT/chemo).
  • Rehabilitation → early physio, speech/cognitive therapy and home program.

What to Expect: Your Care Journey

First Visit (30–60 min): Exam, review scans, counselling and plan.
Pre-Op (1–3 days): Bloods, anaesthesia fitness, navigation planning, insurance pre-auth.
Surgery Day: WHO/NABH checklists, microscopy, IONM as indicated, ICU observation.
Discharge (48–72 hrs typical): Pain control, seizure meds, wound care, red flags.
Follow-Up (7–14 days): Sutures, pathology review.
Long-Term: MRI at 3 months, then per tumor type; rehab and return-to-work plan.

Technology & Innovation

  • Neuronavigation with high-definition microscopy
  • IONM for motor/sensory and cranial nerves
  • PACS/EMR integration for seamless records and tele-follow-ups

Preventing Complications

We aim to reduce infection, CSF leak and neurological deficits through antibiotic stewardship, meticulous closure and physiotherapy-led mobilisation. Seizure education and medication adherence are reinforced at each visit.

Why Ajuda for Brain Tumor Care?

🧭 Image-Guided Precision

Neuronavigation + IONM to protect function during resection.

🏥 ICU-Backed Safety

24/7 neuro ICU, anaesthesia and rapid imaging access.

📲 Coordinated Follow-Up

WhatsApp check-ins, teleconsults and rehab tracking for outcomes.

Take the First Step

Early evaluation improves options and results. Call or WhatsApp 9010550550 to schedule your consultation at Ajuda Hospitals, Hyderabad.

Diagnosis Approach

1

Focused Neuro Exam and Red-Flag Screening

History, fundoscopy and deficit mapping per Indian neurology guidance to stratify urgency.

2

Imaging (MRI Brain ± Contrast; CT for Acute Cases)

ICMR-aligned protocols; diffusion/perfusion sequences for gliomas; venography/angiography as indicated.

3

Tumor Board Review

Neurosurgery, neuro-oncology, radiology and anaesthesia plan resection vs biopsy vs surveillance.

4

Pre-Op Planning and Consent

Neuronavigation registration, IONM planning, blood work and steroid/antiepileptic optimisation.

Treatment Options

Microscope-Assisted Craniotomy

Standard approach for meningiomas, metastases and accessible gliomas using high-illumination optics.

High gross total resection rates in benign tumors
2–4 hrs typical; varies by site/size

Neuronavigation-Guided Resection

Image guidance for precise corticotomy and trajectory planning near eloquent cortex.

Improves accuracy and reduces collateral injury
Adds 10–20 min for registration

Intraoperative Neuro Monitoring (IONM)

Motor/somatosensory evoked potentials and cranial nerve monitoring when near eloquent tracts.

Reduces new neurological deficits
Throughout surgery

Endoscopic Endonasal (Pituitary/Skull Base)

Binostril approach with ENT co-surgery; CSF leak prevention bundles.

Less pain and shorter stay vs open approaches in suitable lesions
1.5–3 hrs typical

Stereotactic Biopsy

Tissue diagnosis for deep/eloquent lesions or when resection is unsafe.

High diagnostic yield with minimal access
Day-care/overnight

Adjuvant Pathway

Neuro-oncology referrals for RT/chemo per NCCN/EANO-adapted protocols after histopathology.

Improves control and survival metrics by subtype
Weeks to months per regimen

Expected Outcomes

Treatment Timeline

24–48 Hours

ICU/ward monitoring, early mobilization, pain and nausea control

1–2 Weeks

Suture removal, return to light desk work if neurologically stable

4–6 Weeks

Pathology review complete; adjuvant therapy starts if indicated

3–6 Months

Rehab goals for strength, speech and cognition; MRI surveillance

Success Metrics

  • Gross/near-total resection in eligible tumors
  • Low new neurological deficit rates
  • Time to adjuvant therapy within 4–6 weeks when indicated